STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

253.25 0.87 −0.34%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) Shares outstanding

Alert me on Shares outstanding

STERIS plc's shares outstanding at the end of fiscal 2026 was $98.7M, unchanged from fiscal 2025. At the end of the quarter to 30 September 2026 it was $97.6M. Over the past ten years it has ranged from $60.0M (fiscal 2015) to $100.2M (fiscal 2023); the current reading is higher than 75% of that period. STERIS plc ranks 32nd of 147 Medical Devices companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2026 $98.7M (0.40%)
FY2025 $99.1M (0.30%)
FY2024 $99.4M (0.84%)
FY2023 $100.2M 1.95%
FY2022 $98.3M 14.47%
FY2021 $85.9M 0.30%
FY2020 $85.6M 0.20%
FY2019 $85.5M (0.29%)
FY2018 $85.7M (0.44%)
FY2017 $86.1M 20.95%

Quarterly newest first

Period Shares outstanding Change
Sep 2026 $97.6M (0.31%)
Jun 2026 $97.9M (0.81%)
Mar 2026 $98.7M 0.10%
Dec 2025 $98.6M (0.20%)
43 more quarters

Against its own ten years

Low $60.0M High $100.2M
Ten-year median $86.0M
Current reading's percentile 75

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on STE